From Ancient Epidemic to Achievable Elimination: (YES! YOU AND I CAN END TB)
Every year on March 24th, the international health community honours the World TB Day, observing Robert Koch’s 1882 discovery of Mycobacterium tuberculosis. World TB Day 2026 is more than a historical remembrance; it is a call to accelerate action against one of humanity’s oldest infectious diseases. Tuberculosis (TB) has existed for millennia, affecting our forefathers long before the era of antibiotics or modern public health innovation. Yet in 2026, we stand at a decisive moment: TB is preventable, diagnosable, and curable. The question is no longer whether we can end TB, but whether we will.
The Global Reality
Tuberculosis remains one of the leading infectious causes of death worldwide. According to the World Health Organization (WHO), an estimated 10.6 million people developed TB in 2022, including 1.3 million children (WHO, 2023a). That same year, 1.3 million HIV-negative individuals died from TB, with an additional 300,000 deaths among people living with HIV (WHO, 2023a). Drug-resistant TB continues to threaten global progress. Approximately 410,000 people developed multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) in 2022, yet treatment coverage remains inadequate (WHO, 2023a). Without expanded access to rapid diagnostics and newer treatment regimens, drug resistance risks reversing decades of progress. Evidently, TB has excessively affected the low- and middle-income countries leading to an increase in conditions of poverty, malnutrition, overcrowding, and limited healthcare access. However, no region is immune. In a globally connected world, infectious diseases cross borders effortlessly.
TB and the Sustainable Development Goals
Ending TB is central to achieving the Sustainable Development Goals (SDGs) adopted by the United Nations in 2015.
- SDG 3 calls for ending the TB epidemic by 2030 (United Nations, 2015).
- SDG 1 (No Poverty) is linked to TB, as the disease both results from and deepens poverty.
- SDG 2 (Zero Hunger) is relevant because undernutrition is a major risk factor for TB progression.
- SDG 10 (Reduced Inequalities) underscores the need to address disparities in access to diagnosis and treatment.
Progress against TB is therefore not only a health priority but a development imperative.
World TB Day 2026 : A Year of Change
Building on global momentum and accountability commitments from recent UN High-Level Meetings on TB, the WHO World TB Day 2026 campaign emphasizes accelerating action, expanding equitable access, and investing in innovation to meet End TB targets. Despite measurable gains, current trajectories remain insufficient to meet the goal of a 90% reduction in TB deaths and an 80% reduction in TB incidence by 2030 compared with 2015 levels (WHO, 2015). World TB Day 2026 must therefore move beyond awareness toward measurable acceleration.
Our Journey towards Scientific Progress: Tools We Now Possess
The scientific landscape offers genuine hope: Existing Digital health tools, artificial intelligence-assisted radiography, and genomic surveillance are transforming early detection and outbreak monitoring. The barrier is no longer scientific capability; it is equitable implementation, with more innovations:
- Rapid molecular diagnostics detect TB and drug resistance within hours.
- Shorter, all-oral regimens for drug-resistant TB have improved tolerability and outcomes.
- TB preventive therapy has become shorter and safer, increasing scalability.
- Vaccine candidates are progressing through advanced clinical trials, with potential to offer stronger protection than BCG (WHO, 2023a).
A Disease Older Than History—But Not Beyond Elimination
Evidence of TB has been identified in ancient Egyptian mummies, confirming that the disease has accompanied humanity for thousands of years (Barberis et al., 2017). Once known as “consumption,” it devastated families long before effective treatment existed. Today, no one should die from tuberculosis. Contributary factors such as funding gaps, delayed diagnosis, stigma, and structural inequities allow TB transmission to continue. According to WHO estimates, millions of TB cases still go undiagnosed or unreported annually (WHO, 2023a). TB persists not because solutions are absent, but because access remains unequal. World TB Day 2026 should mark a turning point. After centuries of coexistence with this pathogen, we possess the knowledge, tools, and strategies to eliminate TB as a public health threat.
The Path Forward
To accelerate progress, global action must focus on:
- Universal access to rapid diagnostics at primary healthcare level.
- Expanded preventive therapy for household contacts and high-risk populations.
- Equitable access to shorter, patient-centered treatment regimens.
- Strengthened surveillance and laboratory systems.
- Integrated TB-HIV services in high-burden settings.
- Sustained financing and political commitment aligned with End TB Strategy targets.
ISID’s commitment to scientific rigor, global collaboration, and workforce strengthening aligns directly with these priorities. Surveillance systems, knowledge-sharing platforms, and capacity-building initiatives remain critical to ensuring that progress is inclusive and evidence-based.
Conclusion
Tuberculosis has walked beside humanity for generations. In 2026, we must ensure it does not walk into the next. The tools exist. The science is clear. The targets are defined. What remains is sustained, coordinated action grounded in equity and global solidarity. Ending TB would not only be a scientific milestone, it would be a moral achievement. World TB Day 2026 must be remembered as the moment we chose acceleration over complacency, equity over disparity, and elimination over endurance.
Written by ISID Emerging Leader, Nelisiwe Lynneth Mhlabane